| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.092 | 0.04 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.088 | 0.06 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.064 | 0.2 |